Protalix BioTherapeutics, Inc. (PLX) Revenue by Year
Protalix BioTherapeutics, Inc. generated $52.7M in revenue in fiscal year 2025. This represents a decrease of 1.2% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $80.6M in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Protalix BioTherapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PLX Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $80.6M | $52.7M-1.2% | $53.4M-18.5% | $65.5M+37.5% | $47.6M+24.2% | $38.4M-39.0% | $62.9M+15.0% | $54.7M+59.7% | $34.2M+62.4% | $21.1M+129.1% | $9.2M+110.8% | $4.4M+23.9% | $3.5M-40.4% | $5.9M-83.0% | $34.9M+315.8% | $8.4M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
PLX Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Protalix BioTherapeutics, Inc. financials
Frequently Asked Questions
What was Protalix BioTherapeutics, Inc.'s revenue in fiscal year 2025?
Protalix BioTherapeutics, Inc. generated $52.7M in revenue in fiscal year 2025.
How fast is Protalix BioTherapeutics, Inc.'s revenue growing?
Protalix BioTherapeutics, Inc. (PLX) revenue fell by 1.2% year over year, from $53.4M to $52.7M in fiscal year 2025.
What is Protalix BioTherapeutics, Inc.'s revenue over the last twelve months?
Protalix BioTherapeutics, Inc. (PLX) reported $80.6M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Protalix BioTherapeutics, Inc.'s revenue changed over the years?
Across the 15 fiscal years this page covers, Protalix BioTherapeutics, Inc. (PLX) revenue went from $8.4M in fiscal year 2011 to $52.7M in fiscal year 2025.
What was Protalix BioTherapeutics, Inc.'s revenue in the most recent quarter?
Protalix BioTherapeutics, Inc. (PLX) reported $19.9M in revenue in Q2 2026. This represents an increase of 27.1% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Protalix BioTherapeutics, Inc. (PLX) reported on that line in every period on record.